Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study

被引:0
|
作者
Nussbaum, Eliezer Zachary [1 ,4 ]
Koo, Sophia [2 ]
Kotton, Camille N. [3 ]
机构
[1] Tufts Med Ctr, Dept Geog Med & Infect Dis, Boston, MA USA
[2] Brigham & Womens Hosp, Div Infect Dis, Boston, MA USA
[3] Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA USA
[4] Tufts Univ, Tufts Med Ctr, Dept Geog Med & Infect Dis, Sch Med, 800 Washington St,Holmes Bldg Off 509, Boston, MA 02111 USA
关键词
solid organ transplant; bacteremia; oral antibiotics; immunocompromised host; THERAPY; TRIAL;
D O I
10.1093/cid/ciae007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background We assessed the safety and efficacy of oral antibiotic step-down therapy for uncomplicated gram-negative blood stream infections in solid-organ transplant recipients.Methods We identified all solid-organ transplant recipients within the Massachusetts General and Brigham and Women's Hospital systems from 2016 to 2021 with uncomplicated gram-negative bacteremia involving an organism susceptible to an acceptably bioavailable oral antibiotic agent. Using inverse probability of treatment-weighted models based on propensity scores adjusting for potential clinical confounders, we compared outcomes of those transitioned to oral antibiotics with those who continued intravenous (IV) therapy for the duration of treatment. Primary endpoints were mortality, bacteremia recurrence, and reinitiation of IV antibiotics. Secondary endpoints included length of stay, Clostridioides difficile infection, treatment-associated complications, and tunneled central venous catheter placement.Results A total of 120 bacteremia events from 107 patients met inclusion criteria in the oral group and 42 events from 40 patients in the IV group. There were no significant differences in mortality, bacteremia recurrence, or reinitiation of IV antibiotics between groups. Patients transitioned to oral antibiotics had an average length of stay that was 1.97 days shorter (95% confidence interval [CI], -.39 to 3.56 days; P = .005). Odds of developing C. difficile and other treatment-associated complications were 8.4 times higher (95% CI, 1.5-46.6; P = .015) and 6.4 times higher (95% CI, 1.9-20.9; P = .002), respectively, in the IV group. Fifty-five percent of patients in the IV group required tunneled catheter placement. There was no difference in treatment duration between groups.Conclusions Oral step-down therapy was effective and associated with fewer treatment-related adverse events. In solid-organ transplant recipients, treatment of uncomplicated gram-negative bloodstream infections with oral antibiotics was safe, effective, and associated with fewer adverse events and shorter length of hospital stay compared with continued intravenous treatment. Graphical Abstract This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/oral-antibiotics-for-treatment-of-gram-negative-bacteremia-in-solid-organ-transplant-recipients-a-propensity-score-weighted-retrospective-observational-study
引用
收藏
页码:208 / 214
页数:7
相关论文
共 50 条
  • [31] Epidemiology, Susceptibility, and Risk Factors Associated with Mortality in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Abdominal Solid Organ Transplant Recipients: A Retrospective Cohort Study
    Di Wu
    Chunmei Chen
    Taohua Liu
    Yan Jia
    Qiquan Wan
    Jie Peng
    Infectious Diseases and Therapy, 2021, 10 : 559 - 573
  • [32] Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
    A L Oliveira
    M de Souza
    V M H Carvalho-Dias
    M A Ruiz
    L Silla
    P Yurie Tanaka
    B P Simões
    P Trabasso
    A Seber
    C J Lotfi
    M A Zanichelli
    V R Araujo
    C Godoy
    A Maiolino
    P Urakawa
    C A Cunha
    C A de Souza
    R Pasquini
    M Nucci
    Bone Marrow Transplantation, 2007, 39 : 775 - 781
  • [33] Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
    Oliveira, A. L.
    de Souza, M.
    Carvalho-Dias, V. M. H.
    Ruiz, M. A.
    Silla, L.
    Tanaka, P. Yurie
    Simoes, B. P.
    Trabasso, P.
    Seber, A.
    Lotfi, C. J.
    Zanichelli, M. A.
    Araujo, V. R.
    Godoy, C.
    Maiolino, A.
    Urakawa, P.
    Cunha, C. A.
    De Souza, C. A.
    Pasquini, R.
    Nucci, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 (12) : 775 - 781
  • [34] Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: A prospective, observational study
    Leibovici, L
    Paul, M
    Poznanski, O
    Drucker, M
    Samra, Z
    Konigsberger, H
    Pitlik, SD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 1127 - 1133
  • [35] Donor-Derived Gram-Negative Infections in Solid Organ Transplant Recipients: OPTN DTAC Experience, 2012-2018
    Pouch, S.
    Plucinski, B.
    La Hoz, R.
    Agarwal, A.
    Aslam, S.
    Danziger-Isakov, L.
    Ho, S.
    Levine, D.
    Malinis, M.
    Rana, M.
    Razonable, R.
    Strasfeld, L.
    Michaels, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 375 - 375
  • [36] Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study
    Chen, Fang
    Shen, Chuan
    Pang, Xiaoyun
    Zhang, Zaili
    Deng, Yuxiao
    Han, Longzhi
    Chen, Xiaosong
    Zhang, Jianjun
    Xia, Qiang
    Qian, Yongbing
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (01)
  • [37] Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study
    Belati, Alessandra
    Diella, Lucia
    Bavaro, Davide Fiore
    De Santis, Laura
    Cotugno, Sergio
    De Gennaro, Nicolo
    Brindicci, Gaetano
    Maggiore, Maria Elena
    Indraccolo, Francesca
    Di Gennaro, Francesco
    Ronga, Luigi
    Mosca, Adriana
    Stufano, Monica
    Dalfino, Lidia
    Grasso, Salvatore
    Saracino, Annalisa
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (02)
  • [38] Predictors of Readmission Following Discharge of Patients With Gram-Negative Bacteremia: A Retrospective Cohort Study
    Porat, Yanay
    Nashashibi, Jeries
    Poran, Itamar
    Paul, Mical
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
  • [39] Comparing Propensity Score Methods Versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections
    Amoah, Joe
    Stuart, Elizabeth A.
    Cosgrove, Sara E.
    Harris, Anthony D.
    Han, Jennifer H.
    Lautenbach, Ebbing
    Tamma, Pranita D.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) : E497 - E505
  • [40] A Propensity Score Analysis Shows that Empirical Treatment with Linezolid Does Not Increase the Thirty-Day Mortality Rate in Patients with Gram-Negative Bacteremia
    Ternavasio-de la Vega, Hugo-Guillermo
    Mateos-Daz, Ana-Maria
    Martinez, Jose-Antonio
    Almela, Manel
    Cobos-Trigueros, Nazaret
    Morata, Laura
    De-la-Calle, Cristina
    Sala, Marta
    Mensa, Josep
    Marcos, Miguel
    Soriano, Alex
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (12) : 7025 - 7031